The Karnataka government has launched legal proceedings against Paschim Banga Pharmaceuticals after the tragic deaths of five women who underwent C-section deliveries at Ballari District Hospital in November. The fatalities have been linked to Ringer’s Lactate IV fluid manufactured by the company, which failed quality tests in state laboratories.
Addressing the Assembly, Health Minister Dinesh Gundu Rao emphasized the government’s commitment to justice for the bereaved families. “A child has lost its mother. Compensation cannot replace the loss, but the company must be held accountable,” he asserted.
A medical panel from the Rajiv Gandhi University of Health Sciences ruled out medical negligence, focusing on the IV fluid as the likely culprit. The Drug Controllers in five districts—Shivamogga, Chikkamagaluru, Haveri, Bengaluru, and Gadag—have filed complaints under the Drugs and Cosmetics Act.
Charges include violations under Sections 18(a)(i) and 27(d), which penalize the manufacturing and sale of substandard or spurious drugs. Convictions under these sections can result in imprisonment of one to two years and a minimum fine of ₹20,000.
The incident has prompted widespread scrutiny of pharmaceutical quality standards and enforcement mechanisms. The government’s strong stance seeks to ensure accountability and prevent future occurrences.
Read Also;